These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27326858)

  • 21. How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.
    Khadem TM; van Manen RP; Brown J
    Pharmacotherapy; 2014 Dec; 34(12):1324-9. PubMed ID: 25421400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.
    Bennett CL; Schooley B; Taylor MA; Witherspoon BJ; Godwin A; Vemula J; Ausdenmoore HC; Sartor O; Yang YT; Armitage JO; Hrushesky WJ; Restaino J; Thomsen HS; Yarnold PR; Young T; Knopf KB; Chen B
    PLoS One; 2019; 14(7):e0219521. PubMed ID: 31365527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mining Drugs and Indications for Suicide-Related Adverse Events.
    Ding T; Chen ES
    AMIA Annu Symp Proc; 2019; 2019():1011-1020. PubMed ID: 32308898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of data mining at the Food and Drug Administration.
    Duggirala HJ; Tonning JM; Smith E; Bright RA; Baker JD; Ball R; Bell C; Bright-Ponte SJ; Botsis T; Bouri K; Boyer M; Burkhart K; Condrey GS; Chen JJ; Chirtel S; Filice RW; Francis H; Jiang H; Levine J; Martin D; Oladipo T; O'Neill R; Palmer LA; Paredes A; Rochester G; Sholtes D; Szarfman A; Wong HL; Xu Z; Kass-Hout T
    J Am Med Inform Assoc; 2016 Mar; 23(2):428-34. PubMed ID: 26209436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System.
    Fusaroli M; Simonsen A; Borrie SA; Low DM; Parola A; Raschi E; Poluzzi E; Fusaroli R
    J Speech Lang Hear Res; 2023 Sep; 66(9):3242-3259. PubMed ID: 37524118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis.
    Andronis C; Silva JP; Lekka E; Virvilis V; Carmo H; Bampali K; Ernst M; Hu Y; Loryan I; Richard J; Carvalho F; Savić MM
    Arch Toxicol; 2020 Aug; 94(8):2829-2845. PubMed ID: 32504122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Alternative to Disproportionality: A Frequency-Based Method for Pharmacovigilance Data Mining.
    Jokinen JD; Lievano F; Scarazzini L; Truffa M
    Ther Innov Regul Sci; 2018 May; 52(3):294-299. PubMed ID: 29714535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repurposing of drugs against bacterial infections: A pharmacovigilance-based data mining approach.
    Ohra S; Sharma R; Kumar A
    Drug Dev Res; 2024 Jun; 85(4):e22211. PubMed ID: 38807372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
    Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
    Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anatomy of Risk Evaluation and Mitigation Strategies (REMS).
    Loeser KK; McKoy JM; Schumock GT
    Cancer Treat Res; 2019; 171():93-105. PubMed ID: 30552659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases.
    Johnson K; Guo C; Gosink M; Wang V; Hauben M
    Bioinformatics; 2012 Dec; 28(23):3123-30. PubMed ID: 23064001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mining in Twitter for adverse events from malaria drugs: the case of doxycycline.
    Duval FV; Silva FABD
    Cad Saude Publica; 2019 May; 35(5):e00033417. PubMed ID: 31141025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program.
    Awada Z; Zgheib NK
    Pharmacogenomics; 2014 Apr; 15(6):845-56. PubMed ID: 24897290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEGylated versus non-PEGylated drugs: A cross-sectional analysis of adverse events in the FDA Adverse Event Reporting System (FAERS) Database
.
    Zhu Z; Gao P; Hu Y; Wang J; Wang H; Yang J; Huang L; Ji C; Ni Y; Fang L
    Int J Clin Pharmacol Ther; 2020 Jun; 58(6):332-342. PubMed ID: 32324132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumothorax as an adverse drug event: an exploratory aggregate analysis of the US FDA AERS database including a confounding by indication analysis inspired by Cornfield's condition.
    Hauben M; Hung EY
    Int J Med Sci; 2013; 10(8):965-73. PubMed ID: 23801882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between Concomitant Use of Acyclovir or Valacyclovir with NSAIDs and an Increased Risk of Acute Kidney Injury: Data Mining of FDA Adverse Event Reporting System.
    Yue Z; Shi J; Li H; Li H
    Biol Pharm Bull; 2018 Feb; 41(2):158-162. PubMed ID: 29187701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
    Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance.
    Zink RC; Huang Q; Zhang LY; Bao WJ
    Chin J Nat Med; 2013 May; 11(3):314-20. PubMed ID: 23725848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.